- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.80 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.3: 12 residues within 4Å:- Chain E: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG.18
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:V.442
- Hydrogen bonds: E:E.209, E:G.376, E:V.442, E:S.207
NAG-NAG-BMA-MAN.8: 12 residues within 4Å:- Chain K: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG.26
1 PLIP interactions:1 interactions with chain K- Hydrophobic interactions: K:V.442
- Hydrogen bonds: K:E.209, K:G.376, K:V.442, K:S.207
NAG-NAG-BMA-MAN.13: 12 residues within 4Å:- Chain Q: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG.34
1 PLIP interactions:1 interactions with chain Q- Hydrophobic interactions: Q:V.442
- Hydrogen bonds: Q:E.209, Q:G.376, Q:V.442, Q:S.207
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 4 residues within 4Å:- Chain E: T.133, Q.135, S.155, N.157
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain E: E.92, N.93
- Chain F: G.13, G.16, S.17
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain E: N.260, P.289, N.444
- Ligands: NAG-NAG-BMA-MAN.3
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain E: N.299, I.320, V.438
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain E: N.336, W.392
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain E: N.360, S.361, T.369, D.383
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain F: E.123, N.126
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain F: N.100, S.102
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain K: T.133, Q.135, S.155, N.157
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain K: E.92, N.93
- Chain L: G.13, G.16, S.17
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain K: N.260, P.289, N.444
- Ligands: NAG-NAG-BMA-MAN.8
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain K: N.299, I.320, V.438
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain K: N.336, W.392
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain K: N.360, S.361, T.369, D.383
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain L: E.123, N.126
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain L: N.100, S.102
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain Q: T.133, Q.135, S.155, N.157
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain Q: E.92, N.93
- Chain R: G.13, G.16, S.17
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain Q: N.260, P.289, N.444
- Ligands: NAG-NAG-BMA-MAN.13
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain Q: N.299, I.320, V.438
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain Q: N.336, W.392
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain Q: N.360, S.361, T.369, D.383
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain R: E.123, N.126
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain R: N.100, S.102
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Caniels, T.G. et al., Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science (2025)
- Release Date
- 2025-05-21
- Peptides
- 61_12A01 heavy chain Fv: AGM
61_12A01 kappa chain Fv: BHN
RM20A3 heavy chain Fv: CIO
RM20A3 light chain Fv: DJP
GT1.1 v4.1 SOSIP gp120: EKQ
Envelope glycoprotein gp160: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HG
KM
PB
LH
NN
RC
GI
JO
OD
IJ
MP
QE
AK
CQ
EF
BL
DR
F
SMTL ID : 9mi0.1
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
61_12A01 heavy chain Fv
Toggle Identical (AGM)61_12A01 kappa chain Fv
Toggle Identical (BHN)RM20A3 heavy chain Fv
Toggle Identical (CIO)RM20A3 light chain Fv
Toggle Identical (DJP)GT1.1 v4.1 SOSIP gp120
Toggle Identical (EKQ)Envelope glycoprotein gp160
Toggle Identical (FLR)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 | 6mu8.1 more...less...6nf2.1 | 6nf5.1 | 6nfc.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mdu.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7t74.1 | 7t75.1 | 7t75.2 | 7t75.3 | 7t9a.1 | 7t9b.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8f92.1 | 8f9m.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8sw4.1 | 8t49.1 | 8t4a.1 | 8t4b.1 | 8t4d.1 | 8t4l.1 | 8tjr.1 | 8tjs.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1 | 8ulr.1 | 8uls.1 | 8ult.1 | 8ulu.1 | 8vfv.1 | 9aug.1 | 9auh.1 | 9aui.1 | 9d1w.1 | 9d3d.1 | 9d8y.1 | 9d98.1 | 9ehl.1 | 9ehm.1 | 9mia.1 | 9mib.1 | 9mih.1 | 9mii.1